A comprehensive view of Drug Delivery/Ingestion. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Pfizer, BioNTech supplying US government with 105 million doses of COVID-19 vaccinations in 30 µg, 10 µg, 3 µg doses in US$3.2B deal; firms to supply Omicron-adapted vaccine if it receives FDA emergency use authorization
Published:
July 01, 2022
by Zack's Commentary
|
FDA grants Breakthrough Therapy Designation for Janssen’s talquetamab injectable antibody to treat relapsed or refractory multiple myeloma, a cancer of plasma cells; multiple myeloma affects 34,000 people in US annually, 176,000 worldwide
Published:
June 30, 2022
by PR Newswire
|
Eli Lilly selling 150,000 doses of monoclonal antibody bebtelovimab co-developed with AbCellera to US government for US$275M, with delivery beginning immediately; bebtelovimab combats COVID-19, offers neutralization activity against all know variants
Published:
June 30, 2022
by Business Wire
|
Children's Hospital Los Angeles collaborates with United Therapeutics on Phase 4 clinical trial to study rapid infusion of Dinutuximab to treat children with high-risk neuroblastoma, a cancer of the nerve cells; study not yet open for recruiting
Published:
June 29, 2022
by Contify Life Science News
|
Bristol Myers Squibb reports mRNA vaccines more effective at developing COVID-19 antibodies in multiple sclerosis patients treated with oral Zeposia ozanimod than non-mRNA vaccines; observation may help in assisting physicians seeking to optimize care
Published:
June 29, 2022
by SeeNews Pharmaceuticals
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count